GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (NYSE:ENZ) » Definitions » Cyclically Adjusted PB Ratio

Enzo Biochem (Enzo Biochem) Cyclically Adjusted PB Ratio : 0.69 (As of Jun. 08, 2024)


View and export this data going back to 1980. Start your Free Trial

What is Enzo Biochem Cyclically Adjusted PB Ratio?

As of today (2024-06-08), Enzo Biochem's current share price is $1.13. Enzo Biochem's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2024 was $1.63. Enzo Biochem's Cyclically Adjusted PB Ratio for today is 0.69.

The historical rank and industry rank for Enzo Biochem's Cyclically Adjusted PB Ratio or its related term are showing as below:

ENZ' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.63   Med: 1.67   Max: 5.26
Current: 0.69

During the past years, Enzo Biochem's highest Cyclically Adjusted PB Ratio was 5.26. The lowest was 0.63. And the median was 1.67.

ENZ's Cyclically Adjusted PB Ratio is ranked better than
77.21% of 136 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.01 vs ENZ: 0.69

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Enzo Biochem's adjusted book value per share data for the three months ended in Jan. 2024 was $1.402. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.63 for the trailing ten years ended in Jan. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Enzo Biochem Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Enzo Biochem's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Cyclically Adjusted PB Ratio Chart

Enzo Biochem Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.17 1.46 2.09 1.50 0.93

Enzo Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 1.61 0.93 0.83 0.77

Competitive Comparison of Enzo Biochem's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Enzo Biochem's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzo Biochem's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Enzo Biochem's Cyclically Adjusted PB Ratio falls into.



Enzo Biochem Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Enzo Biochem's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.13/1.63
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzo Biochem's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2024 is calculated as:

For example, Enzo Biochem's adjusted Book Value per Share data for the three months ended in Jan. 2024 was:

Adj_Book=Book Value per Share/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=1.402/130.1244*130.1244
=1.402

Current CPI (Jan. 2024) = 130.1244.

Enzo Biochem Quarterly Data

Book Value per Share CPI Adj_Book
201404 0.865 100.023 1.125
201407 0.835 100.520 1.081
201410 0.807 100.176 1.048
201501 0.768 98.604 1.014
201504 0.740 99.824 0.965
201507 0.925 100.691 1.195
201510 1.025 100.346 1.329
201601 1.181 99.957 1.537
201604 1.145 100.947 1.476
201607 1.936 101.524 2.481
201610 1.912 101.988 2.439
201701 1.895 102.456 2.407
201704 1.908 103.167 2.407
201707 1.911 103.278 2.408
201710 1.901 104.070 2.377
201801 1.873 104.578 2.331
201804 1.832 105.708 2.255
201807 1.719 106.324 2.104
201810 1.603 106.695 1.955
201901 1.429 106.200 1.751
201904 1.913 107.818 2.309
201907 1.809 108.250 2.175
201910 1.647 108.577 1.974
202001 1.490 108.841 1.781
202004 1.301 108.173 1.565
202007 1.219 109.318 1.451
202010 1.232 109.861 1.459
202101 1.281 110.364 1.510
202104 1.340 112.673 1.548
202107 1.415 115.183 1.599
202110 1.377 116.696 1.535
202201 1.344 118.619 1.474
202204 1.276 121.978 1.361
202207 1.118 125.002 1.164
202210 0.923 125.734 0.955
202301 0.674 126.223 0.695
202304 0.381 127.992 0.387
202307 1.569 128.974 1.583
202310 1.471 129.810 1.475
202401 1.402 130.124 1.402

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Enzo Biochem  (NYSE:ENZ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Enzo Biochem Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzo Biochem (Enzo Biochem) Business Description

Traded in Other Exchanges
Address
527 Madison Avenue, New York, NY, USA, 10022
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Executives
Steven J Pully director 9800 RICHMOND AVE, SUITE 700, HOUSTON TX 77042
James G. Wolf 10 percent owner 105, FLYWAY DRIVE, KIAWAH ISLAND SC 29455
Hamid Erfanian officer: Chief Executive Officer 527 MADISON AVENUE, NEW YORK NY 10022
Patricia Eckert officer: Interim CFO C/O ENZO BIOCHEM, INC., 81 EXECUTIVE BLVD, SUITE 3, FARMINGDALE NY 11735
Kara Cannon officer: Chief Operating Officer 527 MADISON AVE, NEW YORK NY 10022
Bradley Louis Radoff director 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098
David Bench officer: CHIEF FINANCIAL OFFICER ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Harbert Discovery Fund, Lp 10 percent owner HARBERT DISCOVERY FUND GP, LLC, 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203
Ian B. Walters director ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Mary Tagliaferri director 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158
Clemens Peter J Iv 10 percent owner 2383 N. BERRY'S CHAPEL RD., FRANKLIN TN 37069
Rebecca J. Fischer director ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Fabian Blank 10 percent owner, other: See Remarks ROEMERSTRASSE 6, BAD BERTRICH 2M 56864
Harbert Management Corp 10 percent owner 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203
Harbert Discovery Co-investment Fund I Gp, Llc 10 percent owner 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203